• Pharma intelligence

A historic decade of deal-making The biopharma industry is on a roll, continually setting and subsequently breaking records across a range of measures. R&D pipelines, active clinical trials and drug sales are at all-time highs, while the past two years have been the most prolific ever at the US Food and Drug Administration (FDA), which has given the green light to an impressive 120 new chemical or biological entities.
Read more...